PH
Pitango HealthTech
Pitango HealthTech is a seed to Series C stage investment firm. It has made 14 investments. 40% of their portfolio is in Healthcare. Deal activity decreased year-over-year (1 deal in the last 12 months vs 2 prior). Average disclosed round size is $33.4M (across 15 rounds with reported amounts).
Portfolio
14
Fund Size
—
Top Stage
Seed
Last 12 Mo
1
Team
GE
Guy Ezekiel
Managing Partner
HK
Hila Karah
Managing Partner
IH
Ittai Harel
Managing Partner
JG
Jonathan Glazer
Partner
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
15 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Quant Health | Series B | $45M | Aug 2026 |
| RRestore Medical | Series B | $23M | Jul 2025 |
 Somite | Series A | $47M | May 2025 |
 Protai | Seed | $12M | Mar 2023 |
 Carefam | Unknown | $14.5M | Jan 2023 |
 Surge Therapeutics | Series B | $32M | Jan 2023 |
 Connie Health | Series A | $13M | Jul 2021 |
 Medisafe | Series C | $30M | Feb 2021 |
| Connie Health | Series A | $13M | Jan 2021 |
| PProtai Bio | Seed | $12M | — |
 Laguna Health | Seed | $6.6M | — |
 TScan Therapeutics | Series C | $100M | — |
 ImmuneID | Series A | $50M | — |
 guardoc | Seed | $3M | — |
 Tscan | Series C | $100M | — |
Top Co-Investors
Pitango VC8 shared
Khosla Ventures4 shared
Longwood Fund3 shared
Maj Invest2 shared
Grove Ventures2 shared
Sanofi Ventures2 shared
GV2 shared
Novartis Venture Fund2 shared
RA Capital Management2 shared
Bessemer Venture Partners2 shared
Dynamic Loop Capital2 shared
Arkitekt Ventures2 shared
Emerge1 shared
Esplanade Ventures1 shared
Qumra Capital1 shared
GC Ventures1 shared
Peregrine Ventures1 shared
8VC1 shared
Last updated: 20 October 2026